Lublin F, Miller DH, Freedman MS, et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 2016; 387: 1075–84—In this Article, the list of principal investigators in the appendix has been updated. This correction has been made to the online version as of Jan 19, 2017.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jEPv6S
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Objectives Patients undergoing osteoporosis treatment benefit greatly from early detection. We previously developed a computer-...
-
Publication date: Available online 20 March 2018 Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Author(s): Tobia...
-
Cerebral Microbleeds: Imaging and Clinical Significance. Radiology. 2018 Apr;287(1):11-28 Authors: Haller S, Vernooij MW, Kuij...
-
IJMS, Vol. 19, Pages 177: Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy International Journal of Molecular Sciences doi: 10.3390/...
-
Related Articles Physician Dismissal of Families Who Refuse Vaccination: An Ethical Assessment. J Law Med Ethics. 2015;43(3):654-60 ...
-
Chicago's other mag mile: The second-highest-grossing shopping district in the city is a two-mile stretch of 26th Street on the Southwes...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου